iHeart Japan Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$5.43M
- Investors
-
14
iHeart Japan General Information
Description
Developer of a cardiac regenerative medicinal product created to release patients from waiting for heart transplantation and to make it accepted broadly. The company provides a product that utilizes cell differentiation induction technology to attach a cell sheet to the heart to create a vascular network with blood circulation to bring better therapeutic effects and also provides healthcare contract and consulting services, enabling physicians to restore cardiac function as well as other organs such as the liver.
Contact Information
Website
www.iheartjapan.jpCorporate Office
- Creation Core Kyoto Gosha 310
- 448-5 Kajii-cho, Kamigyo -ku
- Kyoto, 604-8221
- Japan
Corporate Office
- Creation Core Kyoto Gosha 310
- 448-5 Kajii-cho, Kamigyo -ku
- Kyoto, 604-8221
- Japan
iHeart Japan Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series D) | 01-Sep-2025 | $5.43M | Completed | Clinical Trials - Phase 2 | ||
| 5. Accelerator/Incubator | 20-Oct-2021 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC (Series C) | 06-Jul-2021 | Completed | Clinical Trials - Phase 2 | |||
| 3. Early Stage VC (Series B) | 19-May-2016 | Completed | Clinical Trials - Phase 2 | |||
| 2. Accelerator/Incubator | 01-Jan-2015 | $2M | Completed | Startup | ||
| 1. Seed Round | 01-Sep-2014 | $2M | $2M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
iHeart Japan Comparisons
Industry
Financing
Details
iHeart Japan Competitors (42)
One of iHeart Japan’s 42 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| Pramomolecular | Accelerator/Incubator Backed | Berlin, Germany | ||||
| Cellaion | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
| Metcela | Venture Capital-Backed | Kawasaki, Japan | ||||
| Histogen | Formerly VC-backed | San Ramon, CA |
iHeart Japan Patents
iHeart Japan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2019024325-A | Method for freezing human pluripotent stem cell-derived cardiomyocytes | Active | 25-Jul-2017 | ||
| JP-6973731-B2 | Method of freezing human pluripotent stem cell-derived cardiomyocytes | Active | 25-Jul-2017 | ||
| JP-2017108705-A | Cardiomyocyte production method | Pending | 18-Dec-2015 | ||
| JP-5924750-B2 | Cd82 positive myocardial progenitor cells | Active | 01-May-2014 | ||
| JP-WO2015166638-A1 | Cd82 positive myocardial progenitor cells | Active | 01-May-2014 | C12N5/0657 |
iHeart Japan Signals
iHeart Japan Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mitsui Sumitomo Kaijo Capital | Corporate Venture Capital | Minority | ||
| J-Startup | Accelerator/Incubator | |||
| Japan Asia Investment | PE/Buyout | Minority | ||
| Kiyo Capital Management | Venture Capital | Minority | ||
| Kyogin Lease Capital | Corporate Venture Capital | Minority |
iHeart Japan FAQs
-
When was iHeart Japan founded?
iHeart Japan was founded in 2013.
-
Where is iHeart Japan headquartered?
iHeart Japan is headquartered in Kyoto, Japan.
-
What is the size of iHeart Japan?
iHeart Japan has 16 total employees.
-
What industry is iHeart Japan in?
iHeart Japan’s primary industry is Drug Discovery.
-
Is iHeart Japan a private or public company?
iHeart Japan is a Private company.
-
What is the current valuation of iHeart Japan?
The current valuation of iHeart Japan is .
-
What is iHeart Japan’s current revenue?
The current revenue for iHeart Japan is .
-
How much funding has iHeart Japan raised over time?
iHeart Japan has raised $21.1M.
-
Who are iHeart Japan’s investors?
Mitsui Sumitomo Kaijo Capital, J-Startup, Japan Asia Investment, Kiyo Capital Management, and Kyogin Lease Capital are 5 of 14 investors who have invested in iHeart Japan.
-
Who are iHeart Japan’s competitors?
Voyager Therapeutics, Pramomolecular, Cellaion, Metcela, and Histogen are some of the 42 competitors of iHeart Japan.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process